148065-10-5Relevant articles and documents
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
Asquith, Christopher R. M.,Awad, Dominik,Catta-Preta, Carolina M. C.,Cou?ago, Rafael M.,Drewry, David H.,Eduful, Benjamin J.,Frigo, Daniel E.,Hossain, Mohammad Anwar,Langendorf, Christopher G.,Liang, Yi,Lin, Chenchu,Nay, Kévin,O'Byrne, Sean N.,Oakhill, Jonathan S.,Picado, Alfredo,Pilotte, Joseph R.,Pulliam, Thomas L.,Santiago, André De S.,Scott, John W.,Temme, Louisa,Wells, Carrow I.,Willson, Timothy M.,Zonzini Ramos, Priscila,Zuercher, William J.
, p. 10849 - 10877 (2021/08/03)
CAMKK2 is a serine/threonine kinase and an activator of AMPK whose dysregulation is linked with multiple diseases. Unfortunately, STO-609, the tool inhibitor commonly used to probe CAMKK2 signaling, has limitations. To identify promising scaffolds as starting points for the development of high-quality CAMKK2 chemical probes, we utilized a hinge-binding scaffold hopping strategy to design new CAMKK2 inhibitors. Starting from the potent but promiscuous disubstituted 7-azaindole GSK650934, a total of 32 compounds, composed of single-ring, 5,6-, and 6,6-fused heteroaromatic cores, were synthesized. The compound set was specifically designed to probe interactions with the kinase hinge-binding residues. Compared to GSK650394 and STO-609, 13 compounds displayed similar or better CAMKK2 inhibitory potency in vitro, while compounds 13g and 45 had improved selectivity for CAMKK2 across the kinome. Our systematic survey of hinge-binding chemotypes identified several potent and selective inhibitors of CAMKK2 to serve as starting points for medicinal chemistry programs.
A modified approach to C-14-labeled 2-(3,4-difluorophenoxy)-5- fluoronicotinic acid and other halogen-substituted analogs
Zhang, Yinsheng,Jian, Zhigang,Stolle, Wayne T.
scheme or table, p. 382 - 386 (2012/06/01)
A modified approach to a carbon-14-labeled pyridine ring system was developed based on the electrocyclic ring-closure of 1,4,4-trisubstituted butadiene. The new method was applied to prepare 2-(3,4-difluorophenoxy)-5- fluoro-[2-14C] nicotinic a
COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS
-
Page/Page column 207-208, (2008/06/13)
The instant invention relates to a combination of an EP4-receptor antagonist and an alpha-2-delta ligand, and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly inflammatory,
